Xometry (NASDAQ:XMTR) Given New $21.00 Price Target at Cantor Fitzgerald

Xometry (NASDAQ:XMTR - Get Free Report) had its price target lifted by stock analysts at Cantor Fitzgerald from $20.00 to $21.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an "underweight" rating on the stock. Cantor Fitzgerald's price objective indicates a potential downside of 30.59% from the stock's previous close.

Other equities analysts have also issued research reports about the stock. Royal Bank of Canada decreased their price target on shares of Xometry from $36.00 to $32.00 and set a "sector perform" rating on the stock in a report on Tuesday, April 29th. JMP Securities restated a "market outperform" rating and set a $42.00 price target on shares of Xometry in a research note on Monday, February 10th. Citigroup decreased their target price on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. JPMorgan Chase & Co. decreased their price objective on shares of Xometry from $45.00 to $30.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Finally, UBS Group raised their target price on shares of Xometry from $22.00 to $33.00 and gave the company a "neutral" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $33.67.

Xometry Trading Down 1.2 %

Shares of Xometry stock traded down $0.36 during trading hours on Wednesday, reaching $30.25. 168,931 shares of the company's stock were exchanged, compared to its average volume of 611,452. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of -28.66 and a beta of 0.71. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. Xometry has a 52-week low of $11.08 and a 52-week high of $45.33. The company has a fifty day moving average of $24.34 and a 200-day moving average of $29.99.

Xometry (NASDAQ:XMTR - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.13) earnings per share (EPS) for the quarter. The business had revenue of $150.97 million during the quarter, compared to analyst estimates of $148.20 million. Xometry had a negative return on equity of 10.16% and a negative net margin of 9.72%. The firm's quarterly revenue was up 23.1% on a year-over-year basis. During the same period in the previous year, the business posted ($0.12) earnings per share. Sell-side analysts forecast that Xometry will post -0.66 EPS for the current fiscal year.

Insider Transactions at Xometry

In related news, CFO James Miln sold 1,346 shares of Xometry stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $25.13, for a total transaction of $33,824.98. Following the transaction, the chief financial officer now owns 144,713 shares of the company's stock, valued at $3,636,637.69. This trade represents a 0.92 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Emily Rollins sold 2,000 shares of the stock in a transaction on Monday, April 7th. The stock was sold at an average price of $20.66, for a total transaction of $41,320.00. Following the sale, the director now directly owns 16,146 shares of the company's stock, valued at $333,576.36. This represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 78,256 shares of company stock valued at $2,012,889. 16.79% of the stock is owned by insiders.

Institutional Investors Weigh In On Xometry

Hedge funds have recently bought and sold shares of the company. Barclays PLC grew its position in Xometry by 360.9% during the third quarter. Barclays PLC now owns 68,951 shares of the company's stock worth $1,266,000 after buying an additional 53,991 shares in the last quarter. Franklin Resources Inc. grew its holdings in Xometry by 32.9% during the 3rd quarter. Franklin Resources Inc. now owns 38,881 shares of the company's stock worth $731,000 after acquiring an additional 9,625 shares during the last quarter. SG Americas Securities LLC grew its position in shares of Xometry by 67.5% in the 4th quarter. SG Americas Securities LLC now owns 13,938 shares of the company's stock valued at $595,000 after buying an additional 5,616 shares during the last quarter. Caprock Group LLC bought a new position in Xometry during the 4th quarter worth approximately $274,000. Finally, Allspring Global Investments Holdings LLC boosted its position in Xometry by 1.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 219,075 shares of the company's stock valued at $9,120,000 after acquiring an additional 2,375 shares during the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.